Li, W;
Lao-Kaim, NP;
Roussakis, AA;
Martin-Bastida, A;
Valle-Guzman, N;
Paul, G;
Loane, C;
... Piccini, P; + view all
(2017)
C-11-PE2I and F-18-Dopa PET for Assessing Progression Rate in Parkinson's: A Longitudinal Study.
Movement Disorders
, 33
(1)
pp. 117-127.
10.1002/mds.27183.
![[thumbnail of Figure1.tiff]](https://discovery.ucl.ac.uk/style/images/fileicons/image.png) |
Image
Figure1.tiff - Accepted Version Access restricted to UCL open access staff Download (1MB) |
|
Image
Figure2.tiff - Accepted Version Access restricted to UCL open access staff Download (4MB) |
![[thumbnail of Foltynie Comparison_of_18F-DOPA_and_11C-PE2I_PET_CLEAN.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text
Foltynie Comparison_of_18F-DOPA_and_11C-PE2I_PET_CLEAN.pdf - Accepted Version Access restricted to UCL open access staff Download (434kB) |
|
Text
Foltynie Tables.pdf - Accepted Version Access restricted to UCL open access staff Download (331kB) |
Abstract
Background 18F-dopa PET measuring aromatic l-amino acid decarboxylase activity is regarded as the gold standard for evaluating dopaminergic function in Parkinson's disease. Radioligands for dopamine transporters are also used in clinical trials and for confirming PD diagnosis. Currently, it is not clear which imaging marker is more reliable for assessing clinical severity and rate of progression. The objective of this study was to directly compare 18F-dopa with the highly selective dopamine transporter radioligand 11C-PE2I for the assessment of motor severity and rate of progression in PD. Methods Thirty-three mild-moderate PD patients underwent 18F-dopa and 11C-PE2I PET at baseline. Twenty-three were followed up for 18.8 ± 3.4 months. Results Standard multiple regression at baseline indicated that 11C-PE2I BPND predicted UPDRS-III and bradykinesia-rigidity scores (P < 0.05), whereas 18F-dopa Ki did not make significant unique explanatory contributions. Voxel-wise analysis showed negative correlations between 11C-PE2I BPND and motor severity across the whole striatum bilaterally. 18F-Dopa Ki clusters were restricted to the most affected putamen and caudate. Longitudinally, negative correlations were found between striatal Δ11C-PE2I BPND, ΔUPDRS-III, and Δbradykinesia-rigidity, whereas no significant associations were found for Δ18F-dopa Ki. One cluster in the most affected putamen was identified in the longitudinal voxel-wise analysis showing a negative relationship between Δ11C-PE2I BPND and Δbradykinesia-rigidity. Conclusions Striatal 11C-PE2I appears to show greater sensitivity for detecting differences in motor severity than 18F-dopa. Furthermore, dopamine transporter decline is closely associated with motor progression over time, whereas no such relationship was found with aromatic l-amino acid decarboxylase. 11C-PE2I may be more effective for evaluating the efficacy of neuroprotective treatments in PD.
| Type: | Article |
|---|---|
| Title: | C-11-PE2I and F-18-Dopa PET for Assessing Progression Rate in Parkinson's: A Longitudinal Study |
| DOI: | 10.1002/mds.27183 |
| Publisher version: | https://doi.org/10.1002/mds.27183 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Clinical Neurology, Neurosciences & Neurology, Parkinson's disease, dopamine transporter, aromatic L-amino acid decarboxylase, C-11-PE2I, F-18-dopa, POSITRON-EMISSION-TOMOGRAPHY, DOPAMINE TRANSPORTER, HUMAN BRAIN, SEROTONIN TRANSPORTER, BETA-CIT, I-123-FP-CIT SPECT, STRIATAL UPTAKE, HIGH-AFFINITY, DISEASE, BINDING |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10044819 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
